| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |